Analyst consensus rating

BioRestorative Therapies Analyst Rating: none

Direct answer

BioRestorative Therapies's consensus rating is none.

1 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $300.00.
Forecast evidence checked November 18, 2026.

Get free BioRestorative Therapies email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Current price
$1.34
Average price target
$300.00
High price target
$300.00
Low price target
$300.00
Low target gap
+22,288.1%
Target upside
+22,288.1%
High target gap
+22,288.1%
Target range width
0%
Consensus rating
none
Analysts
1
Evidence date
November 18, 2026
Valid through
November 25, 2026

Read the frequently asked questions.

What is the analyst consensus rating for BioRestorative Therapies?

BioRestorative Therapies has a verified none consensus. The same dataset has an average price target of $300.00.

How far are BioRestorative Therapies's low and high targets from the recorded price?

The low target implies +22,288.1%, while the high target implies +22,288.1%.

How many analysts are included in BioRestorative Therapies's consensus?

The verified consensus includes 1 analysts.

How is BioRestorative Therapies's target upside or downside calculated?

The average target of $300.00 is divided by the recorded price of $1.34, then one is subtracted to produce +22,288.1%. This does not guarantee a future return.

When was BioRestorative Therapies's analyst forecast verified?

The data was verified on 2026-11-18. The dataset is valid through 2026-11-25.